By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


SEARCH JOBS



Segment
Drug Discovery





Company News
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming Investor Conferences 8/21/2014 7:57:20 AM
PTC Therapeutics, Inc. (PTCT) Release: Orally Delivered Compounds, Which Selectively Modify RNA Splicing Prevent Deficits In Mouse Models Of Spinal Muscular Atrophy 8/8/2014 7:18:13 AM
PTC Therapeutics, Inc. (PTCT) Release: Orally Delivered Compounds, Which Selectively Modify RNA Splicing Prevent Deficits In Mouse Models Of Spinal Muscular Atrophy 8/7/2014 1:46:46 PM
PTC Therapeutics, Inc. (PTCT) Reports Second Quarter Financial Results And Provides Corporate Update 8/7/2014 9:38:29 AM
PTC Therapeutics, Inc. (PTCT) Receives Conditional Approval In The European Union For Translarna™ For The Treatment Of Nonsense Mutation Duchenne Muscular Dystrophy 8/4/2014 7:44:36 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 8/4/2014 6:53:44 AM
PTC Therapeutics, Inc. (PTCT) To Present At The Wedbush Life Sciences Management Access Conference 7/30/2014 9:32:01 AM
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Second Quarter 2014 Financial Results 7/25/2014 8:44:55 AM
PTC Therapeutics, Inc. (PTCT) Announces Expanded Access Program For Translarna™ (ataluren) 7/9/2014 8:44:56 AM
PTC Therapeutics, Inc. (PTCT) Recipient Of Parent Project Muscular Dystrophy's "Path To Progress" Award 6/30/2014 8:59:56 AM
12345678910...
//-->